SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-004081
Filing Date
2023-01-20
Accepted
2023-01-20 16:00:14
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5967
  Complete submission text file 0001213900-23-004081.txt   7534
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARTARA THERAPEUTICS,INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Shefferman Jesse (Reporting) CIK: 0001799167 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 23540915